Turning Point Therapeutics TPTX

$ 75.16 -0.13%

Quarterly report 2022-Q2
added 08-08-2022

Turning Point Therapeutics Balance Sheet 2011-2024 | TPTX

Annual Balance Sheet Turning Point Therapeutics

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-422 M	-550 M	-43.1 M	-101 M	-45 M	-	-	-	-	-	-
Long Term Debt	1.95 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	3.63 M	1.4 M	1.24 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	2.42 M	3.82 M	448 K	66.2 M	-	-	-	-	-	-
Total Current Liabilities	47.1 M	24.4 M	14 M	-	-	-	-	-	-	-	-
Total Liabilities	-	26.8 M	17.9 M	5.77 M	70.8 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-517 M	-280 M	-123 M	-50.8 M	-26 M	-	-	-	-	-	-
Total Assets	1 B	1.14 B	422 M	103 M	45.9 M	-	-	-	-	-	-
Cash and Cash Equivalents	428 M	554 M	48.2 M	101 M	45 M	-	-	-	-	-	-
Book Value	1 B	1.11 B	404 M	97.5 M	-24.8 M	-	-	-	-	-	-
Total Shareholders Equity	954 M	1.11 B	404 M	-48.4 M	-24.8 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Turning Point Therapeutics

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	890 K	1.87 M	1.95 M	2.9 M	3.52 M	2.05 M	2.42 M	2.42 M	2.42 M	2.42 M	3.82 M	3.82 M	3.82 M	3.82 M	448 K	-	448 K	448 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-714 M	-591 M	-517 M	-438 M	-372 M	-316 M	-280 M	-280 M	-280 M	-280 M	-123 M	-123 M	-123 M	-123 M	-50.8 M	-50.8 M	-50.8 M	-50.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	843 M	939 M	1 B	1.06 B	1.1 B	1.13 B	1.14 B	1.14 B	1.14 B	1.14 B	422 M	422 M	422 M	422 M	103 M	103 M	103 M	103 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	290 M	310 M	428 M	404 M	426 M	469 M	554 M	554 M	554 M	554 M	48.2 M	48.2 M	48.2 M	48.2 M	101 M	101 M	101 M	101 M	45 M	-	-	-	12.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	843 M	939 M	1 B	1.06 B	1.1 B	1.13 B	1.14 B	1.14 B	1.14 B	1.14 B	422 M	422 M	422 M	422 M	103 M	103 M	103 M	103 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	793 M	891 M	954 M	1.02 B	1.07 B	1.1 B	1.11 B	1.11 B	1.11 B	1.11 B	404 M	404 M	404 M	404 M	-48.4 M	-48.4 M	-48.4 M	-48.4 M	-24.8 M	-	-	-	-8.66 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency